Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trial of EchiTAb Plus versus EchiTAb G for venomous snakebite in Nigeria
ISRCTN01257358Phase 3Completed
- Sponsor
- Federal Ministry of Health
- Start
- May 2005
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in snakebite envenomation comparing EchiTAb Plus with EchiTAb G (2 arms). Primary endpoints: Restoration of blood coagulability at 6 hours and Blood coagulability over time. Started May 2005; status: completed.
02
Drugs
EchiTAb PlusEchiTAb G
03
Conditions
snakebite envenomation
Beyond the preview
Go deeper on ISRCTN01257358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN01257358.